Ingenuity canonical pathways | -log(p-value) | p-value | Ratio | z-scorea | Number of affected molecules | Total number of moleculesb |
---|---|---|---|---|---|---|
AMPK Signaling | 4.00 | 0.0001 | 0.183 | −0.471 | 30 | 164 |
Hepatic Fibrosis/Hepatic Stellate Cell Activation | 3.76 | 0.0002 | 0.180 | 29 | 161 | |
Acetate Conversion to Acetyl-CoA | 3.55 | 0.0003 | 0.800 | 4 | 5 | |
Ovarian Cancer Signaling | 3.45 | 0.0004 | 0.190 | 23 | 121 | |
cAMP-mediated signaling | 3.25 | 0.0006 | 0.162 | 1.257 | 32 | 197 |
Mitotic Roles of Polo-Like Kinase | 3.08 | 0.0008 | 0.236 | 13 | 55 | |
Glioma Signaling | 3.04 | 0.0009 | 0.198 | 0.258 | 18 | 91 |
Cell Cycle Control of Chromosomal Replication | 2.87 | 0.0013 | 0.308 | 8 | 26 | |
Xenobiotic Metabolism Signaling | 2.79 | 0.0016 | 0.151 | 33 | 218 | |
LXR/RXR Activation | 2.69 | 0.0020 | 0.181 | 0.775 | 19 | 105 |
Calcium Signaling | 2.62 | 0.0024 | 0.161 | 1.698 | 25 | 155 |
Eumelanin Biosynthesis | 2.59 | 0.0026 | 0.750 | 3 | 4 | |
FXR/RXR Activation | 2.50 | 0.0032 | 0.174 | 19 | 109 | |
ATM Signaling | 2.50 | 0.0032 | 0.214 | −1.265 | 12 | 56 |
Ethanol Degradation IV | 2.46 | 0.0035 | 0.333 | 6 | 18 | |
LPS/IL-1 Mediated Inhibition of RXR Function | 2.45 | 0.0035 | 0.151 | 0.378 | 28 | 185 |
Glioma Invasiveness Signaling | 2.43 | 0.0037 | 0.211 | 0.577 | 12 | 57 |
GADD45 Signaling | 2.33 | 0.0047 | 0.316 | 6 | 19 | |
Superpathway of Cholesterol Biosynthesis | 2.31 | 0.0049 | 0.280 | 7 | 25 | |
Oxidative Ethanol Degradation III | 2.26 | 0.0055 | 0.357 | 5 | 14 |